KR101992585B9 - 정맥내 항바이러스 치료 - Google Patents

정맥내 항바이러스 치료

Info

Publication number
KR101992585B9
KR101992585B9 KR1020187005451A KR20187005451A KR101992585B9 KR 101992585 B9 KR101992585 B9 KR 101992585B9 KR 1020187005451 A KR1020187005451 A KR 1020187005451A KR 20187005451 A KR20187005451 A KR 20187005451A KR 101992585 B9 KR101992585 B9 KR 101992585B9
Authority
KR
South Korea
Prior art keywords
antiviral treatments
intravenous
intravenous antiviral
treatments
antiviral
Prior art date
Application number
KR1020187005451A
Other languages
English (en)
Other versions
KR101992585B1 (ko
KR20180024027A (ko
Inventor
얄라가따 수타카라 바부
푸란 챈드
샨타 반티아
쉐인 아놀드
존 마이클 킬패트릭
Original Assignee
바이오크리스트 파마수티컬즈, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101992585(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/en
Application filed by 바이오크리스트 파마수티컬즈, 인코퍼레이티드 filed Critical 바이오크리스트 파마수티컬즈, 인코퍼레이티드
Publication of KR20180024027A publication Critical patent/KR20180024027A/ko
Application granted granted Critical
Publication of KR101992585B1 publication Critical patent/KR101992585B1/ko
Publication of KR101992585B9 publication Critical patent/KR101992585B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020187005451A 2006-02-13 2007-02-12 정맥내 항바이러스 치료 KR101992585B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
US60/772,748 2006-02-13
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments
USPCT/US2006/013535 2006-04-12
KR1020167030296A KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020167030296A Division KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197017311A Division KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Publications (3)

Publication Number Publication Date
KR20180024027A KR20180024027A (ko) 2018-03-07
KR101992585B1 KR101992585B1 (ko) 2019-06-25
KR101992585B9 true KR101992585B9 (ko) 2022-09-20

Family

ID=38169715

Family Applications (9)

Application Number Title Priority Date Filing Date
KR20147030611A KR20140132778A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020187005451A KR101992585B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020167030296A KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020227042429A KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217018500A KR102323339B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020197017311A KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR20147030611A KR20140132778A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020207036259A KR102267754B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Family Applications After (6)

Application Number Title Priority Date Filing Date
KR1020167030296A KR20160129105A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020227042429A KR20230003248A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217018500A KR102323339B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020087022406A KR20080096829A (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020217035812A KR102475176B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료
KR1020197017311A KR102194015B1 (ko) 2006-02-13 2007-02-12 정맥내 항바이러스 치료

Country Status (11)

Country Link
EP (1) EP1986626A1 (ko)
JP (3) JP2009538822A (ko)
KR (9) KR20140132778A (ko)
AU (2) AU2007215156A1 (ko)
BR (1) BRPI0707769A2 (ko)
CA (1) CA2642260C (ko)
EA (1) EA025483B1 (ko)
HK (1) HK1212250A1 (ko)
MX (2) MX2008010394A (ko)
MY (1) MY166063A (ko)
WO (1) WO2007095218A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008010394A (es) * 2006-02-13 2009-01-12 Biocryst Pharm Inc Tratamientos antivirales intravenosos.
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
KR20220033561A (ko) 2020-09-07 2022-03-17 주식회사 경보제약 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735634T2 (de) * 1996-06-14 2007-05-03 Biocryst Pharmaceuticals, Inc., Birmingham Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
AR016162A1 (es) * 1997-12-17 2001-06-20 Biocryst Pharm Inc Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene.
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
MX2008010394A (es) * 2006-02-13 2009-01-12 Biocryst Pharm Inc Tratamientos antivirales intravenosos.

Also Published As

Publication number Publication date
JP2009538822A (ja) 2009-11-12
KR102475176B1 (ko) 2022-12-07
EA025483B1 (ru) 2016-12-30
MY166063A (en) 2018-05-23
CA2642260C (en) 2016-08-09
KR20140132778A (ko) 2014-11-18
KR101992585B1 (ko) 2019-06-25
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
KR20160129105A (ko) 2016-11-08
KR102323339B1 (ko) 2021-11-08
KR102267754B1 (ko) 2021-06-23
KR20080096829A (ko) 2008-11-03
KR20200143519A (ko) 2020-12-23
BRPI0707769A2 (pt) 2011-05-10
KR20190072681A (ko) 2019-06-25
EA200870263A1 (ru) 2009-06-30
MX2020002008A (es) 2020-07-13
CA2642260A1 (en) 2007-08-23
KR20210135632A (ko) 2021-11-15
WO2007095218A1 (en) 2007-08-23
AU2007215156A1 (en) 2007-08-23
EP1986626A1 (en) 2008-11-05
JP6073202B2 (ja) 2017-02-01
MX2008010394A (es) 2009-01-12
JP2015180695A (ja) 2015-10-15
KR20210076189A (ko) 2021-06-23
KR102194015B1 (ko) 2020-12-22
JP2013256527A (ja) 2013-12-26
KR20180024027A (ko) 2018-03-07
HK1212250A1 (en) 2016-06-10
KR20230003248A (ko) 2023-01-05

Similar Documents

Publication Publication Date Title
IL241919A (en) Catheter system
IL196559A0 (en) Combination therapy
GB0712494D0 (en) Substrate reduction therapy
ZA200809559B (en) Photoplethysmography
EP2081483A4 (en) ANTIEXTRAVASATIONSKATHETER
GB0709791D0 (en) Antiviral agents
ZA200806756B (en) Hetero-bycyclic antiviral compounds
GB0624874D0 (en) Treatment
AP2011005695A0 (en) Therapeutic antiviral poptides.
HU3768U (en) Intravenous catheter
IL196556A0 (en) Combination therapy
GB0600692D0 (en) Well treatment
GB0707000D0 (en) Antiviral agents
EP2054061A4 (en) COMBINATION THERAPY
GB0603926D0 (en) Syringes
EP1976590A4 (en) CATHETER
GB0613952D0 (en) Antiviral agent
GB0805264D0 (en) Antiviral agents
GB0625783D0 (en) Medicament
GB0614034D0 (en) Antiviral compounds
ZA200902203B (en) Combination therapy
GB0813307D0 (en) Retro-reflector
ZA200809012B (en) Intravenous antiviral treatments
KR101992585B9 (ko) 정맥내 항바이러스 치료
GB0615064D0 (en) Medicament

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
A107 Divisional application of patent
GRNT Written decision to grant
J204 Request for invalidation trial [patent]
J204 Request for invalidation trial [patent]
J204 Request for invalidation trial [patent]
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J121 Written withdrawal of request for trial
J301 Trial decision

Free format text: TRIAL NUMBER: 2019100003955; TRIAL DECISION FOR INVALIDATION REQUESTED 20191211

Effective date: 20210420

Free format text: TRIAL NUMBER: 2019100003969; TRIAL DECISION FOR INVALIDATION REQUESTED 20191211

Effective date: 20210420

Free format text: TRIAL NUMBER: 2019100003971; TRIAL DECISION FOR INVALIDATION REQUESTED 20191211

Effective date: 20210420

J2X1 Appeal (before the patent court)

Free format text: TRIAL NUMBER: 2021200003772; INVALIDATION

J302 Written judgement (patent court)

Free format text: TRIAL NUMBER: 2021200003772; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20210614

Effective date: 20220708